1Hanessian S,Tehim A,Chen P.Total synthesis of (-)-tetrahydrolipstatin[J].J Org Chem,1993,58 (27):7768-7781.
2Pons J-M,Kocienski P.A synthesis of (-) -tetrahydrolipstatin[J].Tetrahedron Lett,1989,30(14):1833-1836.
3Barbier P,Schneider F,Widmer U.Stereoselective syntheses of tetrahydrolipstatin and of an analogue,potent pancreaticlipase inhibitors containing a β-lactone moiety[J].Helv Chim Acta,1987,70:1412-1418.
4Giese B,Roth M.Diastereoselective radical addition as a keystep in the synthesis of tetrahydrolipstatin[J].J Braz Chem Soc,1996,7 (5):243-246.
5Paterson I,Doughty V-A.Anti-aldol reactions of lactate-derived ketones.Application to the synthesis of (-)-tetrahydrolipstatin[J].Tetrahedron Lett,1999,40(2):393-394.
6Pommier A,Pons J-M,Kocienski P,et al.An Asymmetric Synthesis of (-) -tetrahydrolipstatin[J].Synthesis,1994,1294-1300.
7Dirat O,Kouklovsky C,Langlois Y.Oxazoline N-oxide-Mediated[2+3] cycloadditions.Application to a synthesis of (-)-tetrahydrolipstatin[J].Org Lett,1999,1 (5):753-755.
8Barbier P,Schneider F.Synthesis of tetrahydrolipstatin and tetrahydroesterastin,compounds with a β-lactone moiety.Stereoselective hydrogenation of a β-keto δ-lactone and conversion of the δ-lactone into a β-lactone[J].J Org Chem,1988,53(6):1218-1221.
9Barbier P,Schneider F,Widmer U.Oxetanones and process for their production[P].US:4983746,1991-01-08.(CA1987,106:196249)
10Ghosh AK,Fidanze S.Asymmetric synthesis of (-)-tetrahydrolipstatin:an anti-aldol based strategy[J].Org Lett,2000,2 (16):2405-2407.
5Hanessian S, Tehim A, Chen P. Total synthesis of ( - ) - tetrahydrolipstatin[J]. J Org Chem, 1993,58 (27) :7768 - 7781.
6Barbier P, Schneider F. Syntheses of tetrahydrolipstatin and absolute configuration of tetrahydrolipstatin and |ipstatin [ J ]. Helv Chim Acta, 1987,70 ( 1 ) : 196 - 202.
7Anne B, Steven RP. Orlistat: its current status as an anti - obesity drug [ J ]. Euro J Pharmaco ,2002,440 ( 1 ) : 109 - 117.
8Zhi J, Mulligan TE, Hauptman JB. Long - term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patients[ J]. Clin Pharmacol, 1999,39 ( 1 ) :41 - 46.
9Sjostrom L, Rissanen A, Adersen T, et al. Randomised placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients [ J ]. Lancet, 1998,352 ( 9123 ) : 167 -173.
10Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial[J]. JAMA, 1999,281 ( 3 ) : 235 - 242.
